The RT-qPCR analysis also confirmed that NAP1L1 mRNA expression was significantly enhanced in 24 gliomas tissues as compared to the 24 corresponding para-tumor tissues (P < 0.001) (Figure 1C). The gene discussed is NAP1L1; the disease is central nervous system cancer.